Psychiatric News
Psychiatric News
On October 25, the Food and Drug Administration (FDA) approved the first single-entity extended-release (ER) formulation of hydrocodone bitartrate (Zohydro ER) for management of severe pain that requires daily around-the-clock treatment. Safety and …
Read more on Psychiatric News